Get more info on this report!

Medical Imaging Markets: Molecular Imaging

July 1, 2010

Molecular imaging involves the ability to generate images of specific molecules within
the body. The versatility of medical imaging modalities is continuing to increase as care
givers keep older people alive longer. Age-related diseases such as cancer, stroke and
heart disease represent the highest cost burden to health care in developed countries.

Kalorama Information has been noting developments in these technologies and

rendering the market for them visible to market watchers and business planners.
Medical Imaging Markets: Molecular Imaging offers complete market coverage of world
markets for molecular imaging products for the following technologies:

PET
SPECT-Gamma Camera Systems
MRI
CT
Ultrasound
SPECT/CT
PET/CT

For each of these modalities, the report provides current market size based on
revenues to manufacturers of imaging systems used for molecular procedures, as well
as forecasts of future revenues.

Interest in and use of the technology has exploded in recent years, thanks to advances
in cell biology, biochemical agents, and computer analysis, and serious market
watchers in medical imaging industries, as well as those serving or investing in medical
imaging companies, will want to keep abreast of this new market. As part of its
comprehensive coverage, Medical Imaging Markets: Molecular Imaging includes:

Overview and Explanation of modalities and key applications

Over 25 Figures and Tables to make market data accessible to users
Review of Imaging Agents in Clinical Trials, or that are recently introduced
Market Size and Forecasts are developed through 2014
Profiles of Top Competitors in the industry
Kalorama looks at the technologies currently used in molecular imaging but also
examines novel research areas, such as:

Heart Failure
Breast Biopsies
Treating Thyroid Cancer
Molecular Events
Nanoparticle Platform
Detecting Circulating Progenitor Cells
Molecular Level Tumor Activity
Brain Cell Inflammatory Response
Hybrid Scanner
Semiconductor-Based PET Scanner
PET Scanning Coverage
Motion-Frozen Technology
Recurring Prostate Cancer
Bone Imaging Alternatives
New Perfusion Tracer

Market forecasts are based on an examination of current market conditions and on

investigations into the development of new products by key companies. The market
data provide multiple year forecasts for different product segments covered in the
report. The information presented in this report is the result of data gathered from
company product literature and other corporate brochures and documents, as well as
information found in the scientific and trade press. In addition, interviews were
conducted with company executives, clinicians and researchers.

Table of Contents

TABLE OF CONTENTS

1.0 Executive Summary

1.1 Molecular Basis of Cell Function

1.2 Driving Healthcare
1.3 Two Components
1.4 Key Modalities
1.5 World Market Summary
1.5.1 Market Drivers and Challenges
1.5.2 Growth Analysis
1.6 Methodology

2.0 Introduction

2.1 Definition
2.1.1 For Diagnosis
 2.1.1.1 Molecular Agents
2.2 New Direction for Medicine
2.3 Modalities and Applications
2.3.1 Nuclear Medicine
2.3.1.1 PET
2.3.1.2 SPECT and Gamma Cameras
2.3.2 CT
2.3.3 MRI
2.3.4 Ultrasound
2.3.5 Fusion Imaging
2.3.5.1 PET/CT
2.3.5.2 SPECT/CT
2.4 Optical Imaging
2.5 Drivers
2.6 Issues and Challenges
2.7 Health Care Reform

3.0 Research with Potential

3.1 Heart Failure

3.2 Breast Biopsies
3.3 Treating Thyroid Cancer
3.4 Molecular Events
3.5 Nanoparticle Platform
3.6 Detecting Circulating Progenitor Cells
3.7 Molecular Level Tumor Activity
3.8 Brain Cell Inflammatory Response
3.9 Hybrid Scanner
3.10 Semiconductor-Based PET Scanner
3.11 PET Scanning Coverage
3.12 Motion-Frozen Technology
3.13 Recurring Prostate Cancer
3.14 Bone Imaging Alternatives
3.15 New Perfusion Tracer

4.0 Markets

4.1 Overview
4.2 Procedures
4.3 Forecasts
4.3.1 PET (US/World/Installed Base)
4.3.2 SPECT-Gamma Camera Systems (US/World/Installed Base)
4.3.3 MRI (US/World)
4.3.4 CT (US/World)
4.3.5 Ultrasound (US/World)
4.3.6 Fusion Imaging
 4.3.7 Optical Imaging

5.0 Corporate Profiles

5.1 Advanced Biomarker Technologies

5.2 Agilent Technologies
5.3 Avid Radiopharmaceuticals Inc.
5.4 Bioscan
5.5 Capintec Inc.
5.6 Cardinal Health
5.7 Clinical Data Inc.
5.8 Digirad Corp.
5.9 Dilon Diagnostics
5.10 Gamma Medica-Ideas Inc.
5.11 GE Healthcare
5.12 Hitachi Medical Systems America Inc.
5.13 MIR Preclinical Services
5.14 OptoSonics Inc.
5.15 Philips Healthcare
5.16 PhotoDetection Systems Inc.
5.17 Positron Corp.
5.18 Shimadzu Corp.
5.19 Siemens Healthcare
5.20 Spectrum Dynamics Ltd.
5.21 Toshiba America Medical Systems
5.22 UltraSPECT Ltd.
5.23 VisEn Medical Inc.
5.24 Zecotek Photonics Inc.

LIST OF EXHIBITS

Exhibit 1: World Market for Molecular Imaging

Exhibit 2: Key Liquid Radionuclides
Exhibit 3: Worldwide SPECT Procedures
Exhibit 4: US SPECT Procedures
Exhibit 5: Worldwide PET Procedures
Exhibit 6: US PET Procedures
Exhibit 7: Worldwide Molecular CT Procedures
Exhibit 8: Worldwide Molecular PET Procedures
Exhibit 9: World Medical Market for PET Systems
Exhibit 10: US Medical Market for PET Systems
Exhibit 11: World Medical Market for PET Systems
Exhibit 12: US Medical Market for PET Systems
Exhibit 13: Worldwide Medical PET Installed Base
Exhibit 14: World Medical Market for SPECT Systems
Exhibit 15: US Medical Market for SPECT Systems
 Exhibit 16: World Medical Market for SPECT Systems
Exhibit 17: US Medical Market for SPECT Systems
Exhibit 18: Worldwide Medical SPECT Installed Base
Exhibit 19: World Medical Market for MRI Molecular Imaging Systems
Exhibit 20: US Medical Market for MRI Molecular Imaging Systems
Exhibit 21: World Medical Market for CT Molecular Imaging Systems
Exhibit 22: US Medical Market for CT Molecular Imaging Systems
Exhibit 23: World Medical Market for Ultrasound Molecular Imaging Systems
Exhibit 24: US Medical Market for Ultrasound Molecular Imaging Systems
Exhibit 25: World Medical Market for PET/CT Imaging Systems
Exhibit 26: US Medical Market for PET/CT Imaging Systems
Exhibit 27: World Medical Market for SPECT/CT Imaging Systems
Exhibit 28: US Medical Market for SPECT/CT Imaging Systems

Available immediately for Online Download at

http://www.marketresearch.com/product/display.asp?productid=2613825

US: 800.298.5699

UK +44.207.256.3920

Int'l: +1.240.747.3093

Fax: 240.747.3004